US Stock MarketDetailed Quotes

DRMAW DERMATA THERAPEUTICS INC C/WTS (TO PUR COM)

Watchlist
  • 0.0147
  • 0.00000.00%
Close Jul 19 16:00 ET
0Market Cap0.00P/E (TTM)

DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-63.94%-2.7M
27.45%-6.41M
37.15%-1.15M
30.83%-1.77M
-0.05%-1.84M
36.74%-1.65M
-55.17%-8.83M
-1.20%-1.83M
-15.89%-2.56M
-103.66%-1.84M
Net income from continuing operations
-39.91%-3.13M
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
-41.55%-2.42M
-105.03%-2.73M
Change In working capital
-134.28%-157.43K
662.38%863.68K
327.75%858.2K
50.60%-183.59K
-142.92%-270.18K
1,428.23%459.25K
-153.04%-153.58K
-244.80%-376.82K
41.92%-371.67K
100.15%629.49K
-Change in prepaid assets
-46.00%94.42K
33.42%162.7K
-26.10%151.4K
18.05%-417.55K
-44.12%254K
726.18%174.85K
116.26%121.94K
-20.38%204.87K
-36.68%-509.52K
216.87%454.51K
-Change in payables and accrued expense
-188.55%-251.85K
354.43%700.98K
221.51%706.8K
69.71%233.96K
-399.58%-524.17K
4,374.78%284.4K
-126.50%-275.52K
-20,034.51%-581.69K
151.60%137.85K
-75.13%174.97K
Cash from discontinued investing activities
Operating cash flow
-63.94%-2.7M
27.45%-6.41M
37.15%-1.15M
30.83%-1.77M
-0.05%-1.84M
36.74%-1.65M
-55.17%-8.83M
-1.20%-1.83M
-15.89%-2.56M
-103.66%-1.84M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
0
77.84%7.61M
1.95M
-17,809.50%-35.42K
-64.64%1.51M
4.18M
-73.21%4.28M
0
-100.00%200
4.28M
Net common stock issuance
--0
77.85%7.61M
--1.95M
---35.42K
-64.64%1.51M
--4.17M
-72.21%4.28M
--0
--0
--4.28M
Proceeds from stock option exercised by employees
--0
-34.84%187
--0
--0
-60.92%34
--153
--287
--0
--200
--87
Cash from discontinued financing activities
Financing cash flow
--0
77.84%7.61M
--1.95M
-17,809.50%-35.42K
-64.64%1.51M
--4.18M
-73.21%4.28M
--0
-100.00%200
--4.28M
Net cash flow
Beginning cash position
19.18%7.44M
-42.20%6.24M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
1,935.97%10.8M
-35.99%8.07M
2,387.79%10.63M
515.67%8.19M
Current changes in cash
-207.09%-2.7M
126.26%1.2M
144.19%806.65K
29.44%-1.81M
-113.47%-328.23K
196.84%2.53M
-144.38%-4.56M
-1.16%-1.83M
-121.03%-2.56M
369.81%2.44M
End cash Position
-46.00%4.73M
19.18%7.44M
19.18%7.44M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
-42.20%6.24M
-35.99%8.07M
2,387.79%10.63M
Free cash flow
-63.94%-2.7M
27.45%-6.41M
37.15%-1.15M
30.83%-1.77M
-0.05%-1.84M
36.74%-1.65M
-55.17%-8.83M
-1.20%-1.83M
-15.89%-2.56M
-103.66%-1.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -63.94%-2.7M27.45%-6.41M37.15%-1.15M30.83%-1.77M-0.05%-1.84M36.74%-1.65M-55.17%-8.83M-1.20%-1.83M-15.89%-2.56M-103.66%-1.84M
Net income from continuing operations -39.91%-3.13M18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M-41.55%-2.42M-105.03%-2.73M
Change In working capital -134.28%-157.43K662.38%863.68K327.75%858.2K50.60%-183.59K-142.92%-270.18K1,428.23%459.25K-153.04%-153.58K-244.80%-376.82K41.92%-371.67K100.15%629.49K
-Change in prepaid assets -46.00%94.42K33.42%162.7K-26.10%151.4K18.05%-417.55K-44.12%254K726.18%174.85K116.26%121.94K-20.38%204.87K-36.68%-509.52K216.87%454.51K
-Change in payables and accrued expense -188.55%-251.85K354.43%700.98K221.51%706.8K69.71%233.96K-399.58%-524.17K4,374.78%284.4K-126.50%-275.52K-20,034.51%-581.69K151.60%137.85K-75.13%174.97K
Cash from discontinued investing activities
Operating cash flow -63.94%-2.7M27.45%-6.41M37.15%-1.15M30.83%-1.77M-0.05%-1.84M36.74%-1.65M-55.17%-8.83M-1.20%-1.83M-15.89%-2.56M-103.66%-1.84M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 077.84%7.61M1.95M-17,809.50%-35.42K-64.64%1.51M4.18M-73.21%4.28M0-100.00%2004.28M
Net common stock issuance --077.85%7.61M--1.95M---35.42K-64.64%1.51M--4.17M-72.21%4.28M--0--0--4.28M
Proceeds from stock option exercised by employees --0-34.84%187--0--0-60.92%34--153--287--0--200--87
Cash from discontinued financing activities
Financing cash flow --077.84%7.61M--1.95M-17,809.50%-35.42K-64.64%1.51M--4.18M-73.21%4.28M--0-100.00%200--4.28M
Net cash flow
Beginning cash position 19.18%7.44M-42.20%6.24M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M1,935.97%10.8M-35.99%8.07M2,387.79%10.63M515.67%8.19M
Current changes in cash -207.09%-2.7M126.26%1.2M144.19%806.65K29.44%-1.81M-113.47%-328.23K196.84%2.53M-144.38%-4.56M-1.16%-1.83M-121.03%-2.56M369.81%2.44M
End cash Position -46.00%4.73M19.18%7.44M19.18%7.44M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M-42.20%6.24M-35.99%8.07M2,387.79%10.63M
Free cash flow -63.94%-2.7M27.45%-6.41M37.15%-1.15M30.83%-1.77M-0.05%-1.84M36.74%-1.65M-55.17%-8.83M-1.20%-1.83M-15.89%-2.56M-103.66%-1.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg